Form 4 for ELDN Eledon Pharmaceuticals, Inc.
Accepted 2026-01-16 00:00:00 ET · period of report 2026-01-10 · accession 0001193125-26-015486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-16 | 2026-01-10 | ELDN | Katkin Keith | Dir | M - OptEx | $0.00 | +8,575 | 8,575 | New | $0 |
| D | 2026-01-16 | 2026-01-10 | ELDN | Katkin Keith | Dir | M - OptEx | $0.00 | -8,575 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-10 | M | A | 8,575 | $0.00 | 8,575 | D | — | — | (F1) Represents shares issuable on settlement of restricted stock units ("RSUs") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026. |
| 2 | Derivative | Restricted Stock Units | 2026-01-10 | M | D | 8,575 | $0.00 | 0 | D | — · — to — | 8,575 Common Stock | (F1) Represents shares issuable on settlement of restricted stock units ("RSUs") for common stock on a one-for-one basis granted to the reporting person. The RSUs were issued on January 10, 2025 and vested 100% on January 10, 2026. |